Clinical Trials Directory

Trials / Completed

CompletedNCT04306055

Blood Donor Recruitment During Epidemic of COVID-19

Blood Donor Recruitment During Epidemic of COVID-19 in Guangzhou, China

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19,491 (actual)
Sponsor
Guangzhou Blood Center · Other Government
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.

Detailed description

In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc. The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire with precaution informationEver blood donors in this group would receive a questionnaire which includes some information about how donors can donate safely and how blood center will protect the blood donors during the epidemic of COVID-19.
OTHERExperimental: Questionnaire without precaution informationEver blood donors in this group would receive a questionnaire which dose not include the information above.

Timeline

Start date
2020-03-13
Primary completion
2020-03-13
Completion
2020-04-03
First posted
2020-03-12
Last updated
2020-04-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04306055. Inclusion in this directory is not an endorsement.